Infographic | January 19, 2024

How To Reduce Five Key Risks In Fill and Finish

Source: Terumo BCT
iStock-1088247762-risk

Optimize your fill and finish process through automation. Some of the common risks for cell therapy manufacturers during this phase include human error, process variability, contamination, product inconsistency, and documentation inaccuracies. Systems such as the Finia® Fill and Finish System, de-risk your process and produce strong, consistent results.

 

access the Infographic!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene